Literature DB >> 25380585

Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Jean-Pierre Bouchard1, Louise Cossette, Guillaume Bassez, Jack Puymirat.   

Abstract

Myotonic dystrophy type 1 (DM1) is the most frequent muscular dystrophy in adult. The aim of this study was to investigate the natural history of skeletal muscle weakness in adults, in a cross-sectional, retrospective study. In a cohort of 204 adult DM1 patients, we quantified muscle impairment, handgrip force and physical disability. Muscle strength was similarly affected in the legs and in the arms, the right and left side, and distally more than proximally in patients. The earliest and the most affected skeletal muscles were the digit flexors, foot dorsiflexors and neck flexors; whereas the elbow and knee extensors and flexors were the least affected muscle groups. The rate of decline of the muscle strength was -0.111 units/year. The handgrip values were lower in DM1 patients than the normative values and the rate of decline in handgrip force per year was -0.24 kg. Limitation in mobility or walking is observed in 84 % of DM1 patients but requirement of wheelchair is infrequent (3 %). The decrease in muscle strength, handgrip force and the increase in physical disability were highly correlated with duration of the disease and the number of CTG repeats in the blood. Significant association was found between decline in muscle strength and the age at onset, physical disability and the age of patients at evaluation, handgrip force and gender. Decline in muscle weakness is very slow and although limitation when walking is a common manifestation of DM1 in patients, the requirement of wheelchair is infrequent.

Entities:  

Mesh:

Year:  2014        PMID: 25380585     DOI: 10.1007/s00415-014-7570-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  40 in total

1.  Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions.

Authors:  M-E Arsenault; C Prévost; A Lescault; C Laberge; J Puymirat; J Mathieu
Journal:  Neurology       Date:  2006-04-25       Impact factor: 9.910

2.  Age- and gender-specific normative data of grip and pinch strength in a healthy adult Swiss population.

Authors:  S Werle; J Goldhahn; S Drerup; B R Simmen; H Sprott; D B Herren
Journal:  J Hand Surg Eur Vol       Date:  2009-01-07

3.  Myotonic dystrophy: practical issues relating to assessment of strength.

Authors:  R G Whittaker; E Ferenczi; D Hilton-Jones
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-11       Impact factor: 10.154

4.  Challenges in drug development for muscle disease: a stakeholders' meeting.

Authors:  Jerry R Mendell; Cristina Csimma; Craig M McDonald; Diana M Escolar; Scott Janis; John D Porter; Sharon E Hesterlee; R Rodney Howell
Journal:  Muscle Nerve       Date:  2007-01       Impact factor: 3.217

5.  Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.

Authors:  K E Personius; S Pandya; W M King; R Tawil; M P McDermott
Journal:  Phys Ther       Date:  1994-03

6.  Reliability and validity of the CMT neuropathy score as a measure of disability.

Authors:  M E Shy; J Blake; K Krajewski; D R Fuerst; M Laura; A F Hahn; J Li; R A Lewis; M Reilly
Journal:  Neurology       Date:  2005-04-12       Impact factor: 9.910

7.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

8.  The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study.

Authors:  Luc J Hébert; Jean-François Remec; Joanne Saulnier; Christophe Vial; Jack Puymirat
Journal:  BMC Musculoskelet Disord       Date:  2010-04-18       Impact factor: 2.362

9.  Quantitative motor assessment in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; C L Richards
Journal:  Can J Neurol Sci       Date:  2003-05       Impact factor: 2.104

10.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

View more
  15 in total

1.  Physical function and mobility in children with congenital myotonic dystrophy.

Authors:  Evan M Pucillo; Deanna L Dibella; Man Hung; Jerry Bounsanga; Becky Crockett; Melissa Dixon; Russell J Butterfield; Craig Campbell; Nicholas E Johnson
Journal:  Muscle Nerve       Date:  2017-02-13       Impact factor: 3.217

2.  Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.

Authors:  Lydia Sharp; Diana C Cox; Thomas A Cooper
Journal:  Muscle Nerve       Date:  2019-10-23       Impact factor: 3.217

3.  Predictors of respiratory decline in myotonic dystrophy type 1 (DM1): a longitudinal cohort study.

Authors:  Marco Mazzoli; Alessandra Ariatti; Giancarlo Garuti; Virginia Agnoletto; Riccardo Fantini; Alessandro Marchioni; Giuliana Galassi
Journal:  Acta Neurol Belg       Date:  2020-07-10       Impact factor: 2.396

4.  Increased nuclear but not cytoplasmic activities of CELF1 protein leads to muscle wasting.

Authors:  Diana C Cox; Xiangnan Guan; Zheng Xia; Thomas A Cooper
Journal:  Hum Mol Genet       Date:  2020-06-27       Impact factor: 6.150

5.  Myotonic Dystrophy Type 1 with Syringomyelia in a Young Patient.

Authors:  Xiao-Lin Yu; Ru-Zhen Jia; Pei-Yan Shan; Chuan-Zhu Yan; Ai-Fen Liu
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

6.  Transplantation studies reveal internuclear transfer of toxic RNA in engrafted muscles of myotonic dystrophy 1 mice.

Authors:  Ricardo Mondragon-Gonzalez; Karim Azzag; Sridhar Selvaraj; Ami Yamamoto; Rita C R Perlingeiro
Journal:  EBioMedicine       Date:  2019-08-21       Impact factor: 11.205

7.  Analysis of the functional capacity outcome measures for myotonic dystrophy.

Authors:  Aura Cecilia Jimenez-Moreno; Nikoletta Nikolenko; Marie Kierkegaard; Alasdair P Blain; Jane Newman; Charlotte Massey; Dionne Moat; Jas Sodhi; Antonio Atalaia; Grainne S Gorman; Chris Turner; Hanns Lochmüller
Journal:  Ann Clin Transl Neurol       Date:  2019-07-22       Impact factor: 4.511

Review 8.  Myotonic disorders: A review article.

Authors:  Chris Hahn; Mohammad Kian Salajegheh
Journal:  Iran J Neurol       Date:  2016-01-05

Review 9.  Core Clinical Phenotypes in Myotonic Dystrophies.

Authors:  Stephan Wenninger; Federica Montagnese; Benedikt Schoser
Journal:  Front Neurol       Date:  2018-05-02       Impact factor: 4.003

10.  Change over time in ability to perform activities of daily living in myotonic dystrophy type 1.

Authors:  Erik Landfeldt; Nikoletta Nikolenko; Cecilia Jimenez-Moreno; Sarah Cumming; Darren G Monckton; Catharina G Faber; Ingemar S J Merkies; Grainne Gorman; Chris Turner; Hanns Lochmüller
Journal:  J Neurol       Date:  2020-06-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.